Toragen
About:
Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.
Website: https://toragen.com
Top Investors: Paul Engler
Description:
Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.
Total Funding Amount:
$5.4M
Headquarters Location:
San Diego, California, United States
Founded Date:
2016-01-01
Founders:
Andrew Sharabi
Number of Employees:
11-50
Last Funding Date:
2022-09-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai